Skip to content
Home/Companies/Healthcare/C2S
C2S

C2S

Healthcare·France·Exited 2021·Held 4yr
Entry
2017
Hold
4yr
Exit
2021

Who owns C2S?

C2S is a French Healthcare company, now owned by Elsan, which acquired it in 2021 from Eurazeo.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Eurazeo
Investor
Eurazeo
Eurazeo Patrimoine · 2015 · Real Estate

Key facts

HQFrance
SectorHealthcare
Websitewww.groupec2s.fr
Key takeaways
  • ·Fully exited in 2021 to Elsan.
  • ·Best return: 3.2x MOIC by Eurazeo (2021 exit).
Exit Type
Trade Sale
Buyer
Elsan
MOIC
3.2x
Exit Year
2021

More from Eurazeo Patrimoine

Other portfolio companies in the same fund.

inmemori
Active
ConsumerFrance· 2022
Berlin Portfolio
Active
Real EstateGermany· 2020
Mercure Bordeaux
Active
HospitalityFrance· 2020
Monbuilding.com
Monbuilding.com
Active
PropTechFrance· 2020
Ayre Hoteles
Exited 2026
HospitalitySpain· 2019
to Extendam
Emerige
Emerige
Active
Real EstateFrance· 2019

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns C2S?

C2S is now owned by Elsan, which acquired it in 2021 from Eurazeo.

When did Elsan acquire C2S?

Elsan acquired C2S in 2021, buying from Eurazeo.

Who did C2S sell to?

Eurazeo sold C2S to Elsan in 2021 (Trade Sale), 3.2x return.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue